World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
10371
World Ranking
3079
National Ranking
117

Annemieke Geluk publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Annemieke Geluk sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 208 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Annemieke Geluk D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Annemieke Geluk sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Annemieke Geluk is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on various aspects of infectious diseases, with significant contributions across medical fields such as infectious diseases, epidemiology, surgery, immunology, and rheumatology.

Their research topics encompass a broad range of studies including:

  • Mycobacterium research and diagnosis
  • Leprosy research and treatment
  • Tuberculosis research and epidemiology
  • Infectious diseases and tuberculosis
  • Rheumatoid arthritis research and therapies
  • Systemic lupus erythematosus research
  • SARS-CoV-2 and COVID-19 research

Among recent publications by Annemieke Geluk are the following:

  • RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response, 2020, Scientific Reports
  • Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19, 2021, Nature Immunology
  • Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results, 2021, Clinical Infectious Diseases
  • T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection, 2023, Nature Medicine
  • Mycobacterium leprae transmission characteristics during the declining stages of leprosy incidence: A systematic review, 2021, PLoS Neglected Tropical Diseases

Annemieke Geluk collaborates frequently with the following co-authors:

  • Anouk van Hooij
  • Paul L. A. M. Corstjens
  • Gerhard Walzl
  • Tom H. M. Ottenhoff
  • Louise Pierneef

The most frequent publication venues for Annemieke Geluk's work include:

  • Scientific Reports
  • PLoS Neglected Tropical Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Microbiology
  • Frontiers in Immunology

The body of work strongly aligns with clinical and translational research in infectious diseases, with a pronounced emphasis on tuberculosis and leprosy, as indicated by the concentration of publications and topics.

Best Publications

  • Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1

    Coenraad Kuijl;Nigel D. L. Savage;Marije Marsman;Adriaan W. Tuin

  • Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.

    Nigel D. L. Savage;Tjitske de Boer;Kimberley V. Walburg;Simone A. Joosten

  • Antigenic Equivalence of Human T-Cell Responses to Mycobacterium tuberculosis-Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 and to Mixtures of Synthetic Peptides

    Sandra M. Arend;Annemieke Geluk;Krista E. van Meijgaarden;Jaap T. van Dissel

  • Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.

    Maytal Bivas-Benita;Krista E. van Meijgaarden;Kees L.M.C. Franken;Hans E. Junginger

  • Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

    Simone A. Joosten;Krista E. van Meijgaarden;Nigel D. L. Savage;Tjitske de Boer

  • Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

    Sjoerd H. van der Burg;Maaike E. Ressing;Kitty M.C. Kwappenberg;Annemieke de Jong

  • Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A*0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans

    A. Geluk;K. E. van Meijgaarden;K. L. M. C. Franken;J. W. Drijfhout

  • Frequent Detection of Human Papillomavirus 16 E2-specific T-helper Immunity in Healthy Subjects

    Annemieke de Jong;Sjoerd H. van der Burg;Kitty M. C. Kwappenberg;Jeanette M. van der Hulst

  • Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB

    Novel N Chegou;Jayne S Sutherland;Stephanus Malherbe;Amelia C Crampin

  • Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8+ T-cells with cytotoxic as well as regulatory activity.

    Simone A. Joosten;Krista E. van Meijgaarden;Pascale C. van Weeren;Fatima Kazi

  • Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis.

    Annemieke Geluk;Krista E. van Meijgaarden;Kees L. M. C. Franken;Yanri W. Subronto

  • RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

    Adam Penn-Nicholson;Stanley Kimbung Mbandi;Ethan Thompson;Simon C Mendelsohn

  • Metabolite changes in blood predict the onset of tuberculosis

    January rd Weiner;Jeroen Maertzdorf;Jayne S. Sutherland;Fergal J. Duffy

  • Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19

    Unknown

  • Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity

    Simone A Joosten;Krista E van Meijgaarden;Pascale C van Weeren;Fatima Kazi

  • T-Cell Recognition of the HspX Protein of Mycobacterium tuberculosis Correlates with Latent M. tuberculosis Infection but Not with M. bovis BCG Vaccination

    Annemieke Geluk;May Young Lin;Krista E. van Meijgaarden;Eliane M. S. Leyten

  • Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule

    G. R. Vreugdenhil;A. Geluk;T. H. M. Ottenhoff;W. J. G. Melchers

  • Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.

    May Young Lin;Annemieke Geluk;Steven G. Smith;Amanda L. Stewart

  • Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.

    A Geluk;K E Van Meijgaarden;A A Janson;J W Drijfhout

  • Double- and monofunctional CD4+ and CD8+ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals

    Susanna Commandeur;May Y. Lin;May Y. Lin;Krista E. van Meijgaarden;Annemieke H. Friggen

  • HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.

    A. Geluk;K. E. Van Meijgaarden;S. Southwood;C. Oseroff

Frequent Co-Authors

Tom H. M. Ottenhoff
Tom H. M. Ottenhoff Leiden University Medical Center
Kees L. M. C. Franken
Kees L. M. C. Franken Leiden University Medical Center
Krista E. van Meijgaarden
Krista E. van Meijgaarden Leiden University Medical Center
Abraham Aseffa
Abraham Aseffa Armauer Hansen Research Institute
Jan W. Drijfhout
Jan W. Drijfhout Leiden University Medical Center
Stewart T. Cole
Stewart T. Cole Institut Pasteur
Patrick J. Brennan
Patrick J. Brennan Colorado State University
Simone A. Joosten
Simone A. Joosten Leiden University Medical Center
Hazel M. Dockrell
Hazel M. Dockrell London School of Hygiene & Tropical Medicine
Michèl R. Klein
Michèl R. Klein Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, complementary healthcare degrees offer valuable career pathways. Many professionals begin with foundational programs such as best easiest LPN programs to get into, which provide hands-on clinical skills and open doors to entry-level nursing roles.

Non-nurses seeking to enter the nursing field can explore online nursing programs for non nurses. These programs are designed to transition students smoothly into nursing careers with the flexibility of remote learning.

For accelerated pathways, accelerated BSN programs for non nurses offer a focused curriculum enabling students to earn a Bachelor of Science in Nursing quickly, making them competitive in the job market.

Advanced practice roles can be pursued through easiest nurse practitioner program options, which prepare students for specialized patient care, leadership, and research positions. These varied programs complement Immunology studies by broadening clinical and research career opportunities.

Best Scientists Citing Annemieke Geluk

Trending Scientists

Recently Published Articles